Pharmhouse Corp (PHSE) - Total Liabilities

Latest as of June 2026: $7.42 Million USD

Based on the latest financial reports, Pharmhouse Corp (PHSE) has total liabilities worth $7.42 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Pharmhouse Corp's assets to evaluate the company's liquid asset resilience ratio.

Pharmhouse Corp - Total Liabilities Trend (1996–2025)

This chart illustrates how Pharmhouse Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see PHSE asset base.

Pharmhouse Corp Competitors by Total Liabilities

The table below lists competitors of Pharmhouse Corp ranked by their total liabilities.

Company Country Total Liabilities
EQ Inc.
V:EQ
Canada CA$6.30 Million
Jourdeness Group Ltd
TW:4190
Taiwan NT$5.16 Billion
Elin Electronics Limited
NSE:ELIN
India Rs2.61 Billion
Zaigle Co. Ltd
KQ:234920
Korea ₩29.42 Billion
Premium Snacks Nordic AB
ST:SNX
Sweden Skr130.96 Million
APS Holdings Corporation
KQ:054620
Korea ₩146.52 Billion
Direct Line Insurance Group plc
LSE:DLG
UK GBX6.31 Billion
Johnson Matthey PLC
LSE:JMAT
UK GBX3.90 Billion

Liability Composition Analysis (1996–2025)

This chart breaks down Pharmhouse Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Pharmhouse Corp to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.53 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmhouse Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmhouse Corp (1996–2025)

The table below shows the annual total liabilities of Pharmhouse Corp from 1996 to 2025.

Year Total Liabilities Change
2025-12-31 $8.05 Million +368.40%
2024-12-31 $1.72 Million +378.71%
2023-12-31 $358.92K -9.06%
2022-12-31 $394.66K +207.21%
2021-12-31 $128.47K -52.67%
2020-12-31 $271.45K +596.03%
2019-12-31 $39.00K +1.89%
2018-12-31 $38.27K -10.02%
2017-12-31 $42.54K +21.22%
2015-12-31 $35.09K +76788.69%
2014-12-31 $45.64 -100.00%
1998-12-31 $2.88 Million -43.94%
1997-12-31 $5.13 Million -5.56%
1996-12-31 $5.43 Million --

About Pharmhouse Corp

NASDAQ:PHSE USA Lodging
Market Cap
$49.00 Million
Market Cap Rank
#22106 Global
#4921 in USA
Share Price
$0.02
Change (1 day)
+1.43%
52-Week Range
$0.02 - $0.22
All Time High
$0.22
About

Pride Holdings Group operates as a LGBTQ-focused entertainment, hospitality, and lifestyle company in the United States. It engages in the bar, pub, tavern, restaurant, hotels, nightclubs, and live adult entertainment industry businesses. The company was formerly known as Parliament House Enterprises, Inc. and changed its name to Pride Holdings Group in July 2025. Pride Holdings Group is based in… Read more